Nature Medicine Trial Shows Inhaled siRNA May Calm Lung Inflammation
Nature Medicine reports an early randomized trial of inhaled siRNA targeting RAGE for pulmonary inflammation.
Results and updates from clinical trials testing new drugs, therapies and approaches to care.
Early Pathology Input Strengthens the Future of Cancer Trials, Study Says
A new study says pathology should be embedded early in cancer trial design to improve feasibility and trial quality.
NHS Trial Reports Safer Intravenous Iron Use Before Cardiac Surgery
New BMJ research explores intravenous iron before cardiac surgery and what it could mean for pre-operative anaemia care.
Paxlovid Fails to Ease Long COVID Symptoms in NIH-Funded Trial
Paxlovid did not improve Long COVID symptoms in a large NIH-funded trial published in Lancet Infectious Diseases.
First UK Patient Receives Bespoke Lung Cancer Vaccine in Early Trial
Bespoke lung cancer vaccine given to first UK patient in early MRC-funded trial at Clatterbridge Cancer Centre.
Oxford Starts UK Trial of Ebola Vaccine Against Bundibugyo Strain
Oxford has started a UK Ebola vaccine trial targeting the Bundibugyo strain, marking a fresh step in infectious disease research.
NHS Psilocybin Trial Points to New Path for Treatment-Resistant Depression
An NHS trial found psilocybin-assisted therapy was well tolerated and improved symptoms in treatment-resistant depression.
Oxford Trial Launches UK Ebola Vaccine Study as Researchers Target Rare Strain
Oxford has begun a UK Ebola vaccine trial against the Bundibugyo strain, adding to recent UK medical research advances.
AI-Led Trial Design Could Speed Up Medical Research, Study Suggests
AI system EmulatRx may speed up clinical trial design using real-world patient data, according to a new Nature Communications study.
Oxford begins UK trial of a new Ebola vaccine for the Bundibugyo strain
Oxford has started a UK trial of a fast-developed Ebola vaccine candidate against the Bundibugyo strain.
